Search

As we transition into the endemic phase of the pandemic, companies will have to consider how their mRNA products will be housed and stored.

Experts from Sartorius give advice on the next generation processes and facilities for mRNA manufacture.

The latest issue of The Bioprocess Curator included a lot of interesting news about vaccines. In case you missed it, here's some of the top stories.

The development of a CMV vaccine has been 50 years in the making.

In our second C+G Champions installment, we ask industry leaders in the cell and gene field to answer key questions about the industry.

How can our knowledge of mRNA vaccine development influence our Industry 4.0 journeys?

When it comes to influenza, chicken egg-based vaccines have achieved much, but emerging approaches are ready to fly the coop.

More researchers are exploring the potential of mRNA encapsulation into lipid nanoparticles.

From hemispheric analysis to hatchery logistics, there’s a lot more to vaccine production than you might suspect

The analytical complexities that come with oligonucleotide manufacturing are difficult, but not impossible.